These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 8059829

  • 1. Different pattern of zymography between human gynecologic normal and malignant tissues.
    Tamakoshi K, Kikkawa F, Nawa A, Maeda O, Kawai M, Sugamuma N, Yamagata S, Tomoda Y.
    Am J Obstet Gynecol; 1994 Aug; 171(2):478-84. PubMed ID: 8059829
    [Abstract] [Full Text] [Related]

  • 2. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form.
    Tamakoshi K, Kikkawa F, Nawa A, Ishikawa H, Mizuno K, Tamakoshi A, Yamagata S, Suganuma N, Tomoda Y.
    Cancer; 1995 Dec 15; 76(12):2565-71. PubMed ID: 8625086
    [Abstract] [Full Text] [Related]

  • 3. [Regulation of matrix-degrading enzymes in gynecologic cancer tissues and cells].
    Kikkawa F.
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug 15; 48(8):618-22. PubMed ID: 8808829
    [Abstract] [Full Text] [Related]

  • 4. Positive correlation between inhibitors of matrix metalloproteinase 1 and matrix metalloproteinases in malignant ovarian tumor tissues.
    Kikkawa F, Tamakoshi K, Nawa A, Shibata K, Yamagata S, Yamagata T, Suganuma N.
    Cancer Lett; 1997 Nov 25; 120(1):109-15. PubMed ID: 9570393
    [Abstract] [Full Text] [Related]

  • 5. Hyaluronidase activity in gynaecological cancer tissues with different metastatic forms.
    Tamakoshi K, Kikkawa F, Maeda O, Suganuma N, Yamagata S, Yamagata T, Tomoda Y.
    Br J Cancer; 1997 Nov 25; 75(12):1807-11. PubMed ID: 9192986
    [Abstract] [Full Text] [Related]

  • 6. Pyrimidine nucleoside phosphorylase activity in normal tissues of the uterus and ovary and in benign and malignant lesions of these organs.
    Suzuki M, Usui N, Furugen Y, Mitsuhasi N.
    Int J Clin Oncol; 2001 Feb 25; 6(1):19-24. PubMed ID: 11706522
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation.
    Zhang J, Salamonsen LA.
    J Clin Endocrinol Metab; 2002 May 25; 87(5):2346-51. PubMed ID: 11994386
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E, Schmalfeldt B, Konik E, Späthe K, Härting K, Fenn A, Berger U, Fridman R, Schmitt M, Prechtel D, Kuhn W.
    Gynecol Oncol; 2001 Aug 25; 82(2):291-8. PubMed ID: 11531282
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Type-IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues.
    Takemura M, Azuma C, Kimura T, Kanai T, Saji F, Tanizawa O.
    Int J Gynaecol Obstet; 1994 Sep 25; 46(3):303-9. PubMed ID: 7806000
    [Abstract] [Full Text] [Related]

  • 14. Focal expression and final activity of matrix metalloproteinases may explain irregular dysfunctional endometrial bleeding.
    Galant C, Berlière M, Dubois D, Verougstraete JC, Charles A, Lemoine P, Kokorine I, Eeckhout Y, Courtoy PJ, Marbaix E.
    Am J Pathol; 2004 Jul 25; 165(1):83-94. PubMed ID: 15215164
    [Abstract] [Full Text] [Related]

  • 15. Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production.
    Azzam HS, Arand G, Lippman ME, Thompson EW.
    J Natl Cancer Inst; 1993 Nov 03; 85(21):1758-64. PubMed ID: 8411260
    [Abstract] [Full Text] [Related]

  • 16. High levels of gelatinase-B and active gelatinase-A in metastatic glioblastoma.
    Forsyth PA, Laing TD, Gibson AW, Rewcastle NB, Brasher P, Sutherland G, Johnston RN, Edwards DR.
    J Neurooncol; 1998 Jan 03; 36(1):21-9. PubMed ID: 9525822
    [Abstract] [Full Text] [Related]

  • 17. Cell-matrix interactions modulate 92-kD gelatinase expression by human bronchial epithelial cells.
    Yao PM, Delclaux C, d'Ortho MP, Maitre B, Harf A, Lafuma C.
    Am J Respir Cell Mol Biol; 1998 Jun 03; 18(6):813-22. PubMed ID: 9618386
    [Abstract] [Full Text] [Related]

  • 18. The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation.
    Paju A, Sorsa T, Tervahartiala T, Koivunen E, Haglund C, Leminen A, Wahlström T, Salo T, Stenman UH.
    Br J Cancer; 2001 May 18; 84(10):1363-71. PubMed ID: 11355948
    [Abstract] [Full Text] [Related]

  • 19. Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase: associated activation of gelatinase A, gelatinase B and collagenase 3.
    Cowell S, Knäuper V, Stewart ML, D'Ortho MP, Stanton H, Hembry RM, López-Otín C, Reynolds JJ, Murphy G.
    Biochem J; 1998 Apr 15; 331 ( Pt 2)(Pt 2):453-8. PubMed ID: 9531484
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.